[Anesthetic management using HemoSonic 100 in a patient with chronic renal failure and dilated cardiomyopathy]

Nobuhiro Noguchi1, Manabu Kakinohana, Kazuhiro Sugahara

  • 1Department of Anesthesiology, Faculty of Medicine, University of the Ryukyus, Okinawa 903-0215.

Masui. the Japanese Journal of Anesthesiology
|July 10, 2004
PubMed

Insights

HemoSonic 100 monitoring helped manage anesthesia during a nephrectomy in a patient with chronic renal failure and dilated cardiomyopathy (DCM). Left ventricular ejection time (LVETc) guided transfusion needs, ensuring a stable circulatory condition.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Nephrology

Background:

  • Anesthetic management for nephrectomy in patients with comorbidities like chronic renal failure and dilated cardiomyopathy (DCM) presents unique challenges.
  • Utilizing advanced monitoring is crucial for maintaining hemodynamic stability during complex surgical procedures.

Observation:

  • A patient with chronic renal failure and DCM underwent nephrectomy under anesthesia.
  • Propofol, ketamine, and fentanyl were used for anesthesia induction and maintenance.
  • Left ventricular ejection time (LVETc) was monitored using HemoSonic 100.

Findings:

  • Active bleeding from the renal artery led to a decrease in LVETc.
  • LVETc provided critical data for assessing adequate preload and guiding transfusion rates.
  • The HemoSonic 100 proved valuable in managing the patient's circulatory condition.

Implications:

  • HemoSonic 100 serves as a useful tool for anesthetic management in patients with DCM, particularly for preload assessment.
  • This case highlights the importance of continuous hemodynamic monitoring in high-risk surgical patients.
  • Effective anesthetic strategies can lead to successful surgical outcomes even in patients with significant comorbidities.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...